All In Biotech

Drug Trial Radar · NCT03364153

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

Last checked: Nov 20, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 121 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

121

Actual

Start

Jan 12, 2018

Primary completion

Mar 31, 2025

Study completion Mar 31, 2025

Sponsor

Lead sponsor
Astellas Pharma Global Development, Inc.Astellas (ALPMY)
Sponsor type
Industry
First posted
Dec 6, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of avacincaptad pegol intravitreal injection compared to Sham in participants with autosomal recessive Stargardt disease 1 (STGD1).

Conditions

  • Stargardt's Macular Dystrophy

Interventions

  • avacincaptad pegolDrug

    Intravitreal Injection

  • ShamDrug

    Intravitreal Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Rate of Change in the Area of Ellipsoid Zone Defect From Baseline Through Month 18Time frame: Baseline to Month 18

Locations

41 sites in 8 countries. Site status is shown where the registry gives one.

  • Retinal Research Institute

    Phoenix, Arizona

  • Jules Stein Eye Institute/ David Geffen School of Medicine

    Los Angeles, California

  • VitreoRetinal Associates

    Gainesville, Florida

  • Retina Specialty Institute

    Pensacola, Florida

  • Wilmer Eye Institute, Johns Hopkins

    Baltimore, Maryland

  • Ophthalmic Consultants of Boston

    Boston, Massachusetts

  • University of Michigan/Kellogg Eye Center

    Ann Arbor, Michigan

  • The Retina Center

    Minneapolis, Minnesota

  • Retina Center of NJ, LLC.

    Bloomfield, New Jersey

  • Casey Eye Institute/Oregon Health & Science University

    Portland, Oregon

  • Wills Eye Hospital/Mid Atlantic Retina

    Philadelphia, Pennsylvania

  • UPMC Eye Center

    Pittsburgh, Pennsylvania

  • Palmetto Retina Center

    West Columbia, South Carolina

  • Austin Retina Associates

    Austin, Texas

  • Retina Foundation of the Southwest

    Dallas, Texas

  • Strategic Clinical Research Group

    Willow Park, Texas

  • University of Utah John A. Moran Eye Center

    Salt Lake City, Utah

  • Creteil University Eye Clinic University Paris EST

    Créteil, France

  • Centre ophtalmologique des Quinzes Vingts

    Paris, France

  • Hopital de la Croix-Rousse

    Lyon, Auvergne-Rhône-Alpes, France

  • University of Bonn

    Bonn, Germany

  • Augenklinik der LMU München

    München, Germany

  • University of Tuebingen

    Tübingen, Germany

  • Budapest Retina Institute

    Budapest, Hungary

  • Semmelweis Egyetem

    Budapest, Hungary

  • University of Debrecen DE KK Szemészeti Klinika

    Debrecen, Hungary

  • Ganglion Medical Center

    Pécs, Hungary

  • Szegedi Tudomanyegyetem, Szent-Gyorgyi Albert Klinikai Kozpont, Szemeszeti Klinika

    Szeged, Hungary

  • Rambam Health Care Campus

    Haifa, Israel

  • Hadassah University Hospital

    Jerusalem, Israel

  • Rabin Medical Center, Beilinson campus

    Petah Tikva, Israel

  • Kaplan Medical Center

    Rehovot, Israel

  • Tel-Aviv Sourasky Medical Center, Ichilov Hospital

    Tel Aviv, Israel

  • AOU Policlinico Sant'Orsola Malpighi, U.O. Oftalmologia,

    Bologna, Italy

  • Azienda Ospedaliera Universitaria Careggi

    Florence, Italy

  • Ospedale San Raffaele

    Milan, Italy

  • University of Campania Luigi Vanvitelli Eye Clinic

    Naples, Italy

  • Fondazione Policlinico Tor Vergata, UOSD Patologie Retiniche

    Rome, Italy

  • Institut de la Macula

    Barcelona, Spain

  • Princess Alexandra Eye Pavillion

    Edinburgh, United Kingdom

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.